After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Gain valuable insights from women's financial planning case studies. Learn from real-life experiences to enhance your financial strategy.
22,562 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
New Delhi hosted talks that produced a joint road map on economic security and deeper cooperation across AI, shipbuil...
A rising wave in artificial intelligence memory is reshaping tech demand. Learn how to profit with under $100 through...
Memory markets are shifting as mega-capex from Hynix and Samsung could ease shortages. Here's what that means for Mic...
The Nasdaq 100 ETF is seeing its busiest month in years as traders chase SpaceX exposure, aided by new weighting rule...
Dream Finders has offered cash to acquire Beazer at roughly $32 per share, elevating the stakes for both companies. T...
A growing share of Americans are skipping books, a trend that billionaires say they avoided as well. Experts warn the...
The White House announced a renewed naval blockade of Iranian shipping through the Strait of Hormuz and a 20% toll on...
Morgan Stanley reveals a sharper cost curve for AI data centers, suggesting only a few players can fund the next wave...
Nvidia investors should watch TSMC's latest results closely. When the world’s largest chipmaker signals stronger dema...
A brief 15-word remark from a Federal Reserve governor sparked a big market conversation. This analysis breaks down w...
In a late-day turn, Bill Gates pulled out of India’s AI Impact Summit hours before his keynote, amplifying concerns o...